On Feb 03, 2026, PFE reported earnings of 0.66 USD per share (EPS) for Q4 25, beating the estimate of 0.57 USD, resulting in a 14.29% surprise. Revenue reached 17.56 billion, compared to an expected 17.12 billion, with a 2.56% difference. The market reacted with a -3.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 14 analysts forecast an EPS of 0.73 USD, with revenue projected to reach 14.03 billion USD, implying an increase of 10.61% EPS, and decrease of -20.09% in Revenue from the last quarter.
FAQ
What were Pfizer Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Pfizer Inc. reported EPS of $0.66, beating estimates by 14.29%, and revenue of $17.56B, 2.56% above expectations.
How did the market react to Pfizer Inc.'s Q4 2025 earnings?
The stock price moved down -3.34%, changed from $26.66 before the earnings release to $25.77 the day after.
When is Pfizer Inc. expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for Pfizer Inc.'s next earnings report?
Based on 14
analysts, Pfizer Inc. is expected to report EPS of $0.73 and revenue of $14.03B for Q1 2026.